Soligenix Inc (SNGX)
3.31
-0.05
(-1.49%)
USD |
NASDAQ |
Nov 22, 16:00
3.28
-0.03
(-0.91%)
After-Hours: 20:00
Soligenix Free Cash Flow: -7.999M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -7.999M |
| June 30, 2024 | -7.775M |
| March 31, 2024 | -7.780M |
| December 31, 2023 | -8.604M |
| September 30, 2023 | -10.40M |
| June 30, 2023 | -10.97M |
| March 31, 2023 | -11.58M |
| December 31, 2022 | -12.66M |
| September 30, 2022 | -12.09M |
| June 30, 2022 | -11.88M |
| March 31, 2022 | -11.00M |
| December 31, 2021 | -11.74M |
| September 30, 2021 | -12.81M |
| June 30, 2021 | -12.76M |
| March 31, 2021 | -12.74M |
| December 31, 2020 | -11.46M |
| September 30, 2020 | -9.980M |
| June 30, 2020 | -9.047M |
| March 31, 2020 | -7.918M |
| December 31, 2019 | -7.510M |
| September 30, 2019 | -7.542M |
| June 30, 2019 | -6.452M |
| March 31, 2019 | -8.079M |
| December 31, 2018 | -7.247M |
| September 30, 2018 | -6.913M |
| Date | Value |
|---|---|
| June 30, 2018 | -7.158M |
| March 31, 2018 | -6.369M |
| December 31, 2017 | -6.537M |
| September 30, 2017 | -5.620M |
| June 30, 2017 | -5.612M |
| March 31, 2017 | -5.976M |
| December 31, 2016 | -4.990M |
| September 30, 2016 | -4.90M |
| June 30, 2016 | -4.038M |
| March 31, 2016 | -4.533M |
| December 31, 2015 | -5.408M |
| September 30, 2015 | -4.445M |
| June 30, 2015 | -5.105M |
| March 31, 2015 | -3.628M |
| December 31, 2014 | -2.518M |
| September 30, 2014 | -3.445M |
| June 30, 2014 | -4.164M |
| March 31, 2014 | -4.138M |
| December 31, 2013 | -4.475M |
| September 30, 2013 | -3.517M |
| June 30, 2013 | -2.528M |
| March 31, 2013 | -2.709M |
| December 31, 2012 | -2.640M |
| September 30, 2012 | -3.520M |
| June 30, 2012 | -0.0511M |
Free Cash Flow Range, Past 5 Years
-12.81M
Minimum
Sep 2021
-7.510M
Maximum
Dec 2019
-10.44M
Average
-10.99M
Median
Free Cash Flow Benchmarks
| Tonix Pharmaceuticals Holding Corp | -69.19M |
| Lixte Biotechnology Holdings Inc | -3.468M |
| Shuttle Pharmaceuticals Holdings Inc | -5.699M |
| NovaBay Pharmaceuticals Inc | -4.812M |
| Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -2.910M |
| Cash from Financing (Quarterly) | 3.293M |
| Free Cash Flow Per Share (Quarterly) | -1.321 |
| Free Cash Flow Yield | -202.6% |